Natural Capsules Share Price in Focus as Subsidiary Inks Deals with Fermbox Bio to Expand CDMO Services

Natural Biogenex Private Limited, a subsidiary of Natural Capsules Limited, has entered into strategic Framework and Contract Manufacturing Agreements with Fermbox Bio Private Limited. This collaboration aims to enhance fermentation-based Contract Development and Manufacturing (CDMO) services. 

Details of the Strategic Collaboration 

Under the agreements, Fermbox Bio will provide advanced fermentation technology and equipment worth up to ₹60 crore at Natural Biogenex's facility in Tumkur. Natural Biogenex will focus on licensed manufacturing, quality assurance, and regulatory compliance. This collaboration positions the company to serve global biotechnology and biopharma clients with integrated, GMP-compliant manufacturing capabilities. 

The global biotech and biopharma CDMO market is experiencing significant growth, driven by rising demand and increasing outsourcing. India is well-positioned to capture a substantial share of this market, leveraging its biomanufacturing strength and expanding CDMO sector. 

India's Strategic Position in the CDMO Market 

Key government initiatives like the BioE3 Policy and the RDI initiative are accelerating innovation and scaling up the biomanufacturing ecosystem in India. This collaboration between Natural Biogenex and Fermbox Bio is set to benefit from these developments. 

Read More: Aarti Industries Signs $150 Million Supply Deal With Global Agrochemical Company! 

Comments from Leadership 

Mr. Sunil Laxminarayana Mundra, Managing Director of Natural Capsules Limited, stated that this partnership marks a significant step for Natural Biogenex in expanding into high-value, fermentation-based bio-manufacturing CDMO services. The collaboration combines Natural Biogenex's manufacturing strength and regulatory expertise with Fermbox Bio's advanced technology. 

About Natural Capsules Limited 

Natural Capsules Limited is a leading manufacturer of hard capsule shells in India, pioneering vegetarian capsule production. Incorporated in 1993, the company has expanded its operations and is now venturing into API manufacturing through its subsidiary, Natural Biogenex Private Limited. 

Natural Capsules Share Price Performance 

As of March 12, 2026, at 3:30 PM, Natural Capsules share price on NSE was closed at ₹151.70 up by 0.46% from the previous closing price. 

Conclusion 

The strategic agreements between Natural Biogenex and Fermbox Bio are set to enhance CDMO capabilities, aligning with India's growing biomanufacturing sector. This collaboration underscores the potential for scalable growth in pharmaceutical and industrial biotech segments. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.